Recursion Pharmaceuticals Inc (RXRX) — Capital Reinvestment Ratio

Latest as of March 2022: 0.06x

Recursion Pharmaceuticals Inc (RXRX) has a Capital Reinvestment Ratio of 0.06x as of March 2022, meaning it reinvests 0% of its operating cash flow ($77.39 Million) in capital expenditures ($4.34 Million). See Recursion Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.06x
Capex / Operating Cash Flow

Operating Cash Flow

$77.39 Million
USD

Capital Expenditures

$4.34 Million
USD

Data as of

Mar 2022
Most recent filing

Annual Capital Reinvestment Ratio for Recursion Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Recursion Pharmaceuticals Inc from None to None. For live market cap and broader valuation context, see Recursion Pharmaceuticals Inc stock valuation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow